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Primary Sjögren’s syndrome (pSS) is an autoimmune disease affecting exocrine
glands and extra-glandular organs. There are conflicting reports on the presence of
autonomic dysfunction in pSS and no data are available on the functional status
of sympathetic outflow to the vessels and baroreceptor [baroreflex sensitivity (BRS)]
control mechanisms. We investigated the cardiac (cBRS) and sympathetic (sBRS)
baroreceptor modulation in both time and frequency domains and the cardiovascular
autonomic profile in pSS patients compared to healthy controls. Autonomic symptoms
were quantified by the Composite Autonomic Symptom Scale (COMPASS31) three-
item questionnaire. The EULAR Sjogren’s syndrome patient reported index (ESSPRI)
questionnaire evaluated the magnitude of pSS clinical symptoms, i.e., fatigue, pain, and
sicca symptoms. Electrocardiogram, beat-by-beat arterial pressure (AP) and respiratory
activity were continuously recorded in 17 pSS patients and 16 healthy controls, while
supine and during 75◦ head-up tilt. In seven patients and seven controls, muscle
sympathetic nerve activity (MSNA) was measured. Spectrum analysis of RR variability
provided markers of cardiac vagal modulation (HFRR nu) and sympatho-vagal balance
[low frequency (LF)/high frequency (HF)]. The power of LF (0.1 Hz) oscillations of
systolic arterial pressure (SAP) variability (LFSAP) evaluated the vasomotor response to
sympathetic stimulation. Compared to controls, pSS patients scored higher in total
COMPASS31 (p < 0.0001) and all ESSPRI subdomains (fatigue, p = 0.005; pain,
p = 0.0057; dryness, p< 0.0001). Abnormal scialometry (<1.5 ml/15 min) and Schirmer
tests (<5 mm/5 min) were found in pSS patients and salivary flow rate was negatively
associated with ESSPRI dryness (p = 0.0014). While supine, pSS patients had lower
SEQcBRS index of cardiac baroreceptor sensitivity, higher HFRRnu (p = 0.021), lower
LF/HF (p = 0.007), and greater MSNA (p = 0.038) than controls. No differences
were observed in LFSAP between groups. During orthostatic challenge, although LFSAP
increased similarly in both groups, MSNA was greater in pSS patients (p = 0.003). At
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rest pSS patients showed lower cBR control and greater parasympathetic modulation.
Furthermore, greater sympathetic nerve activity was observed in pSS patients while
supine and in response to gravitational challenge. We hypothesized that such enhanced
sympathetic vasoconstrictor activity might reflect an attempt to maintain blood pressure
in a setting of likely reduced vascular responsiveness.
Keywords: primary Sjogren’s syndrome, baroreceptor activity, power spectrum analysis, heart rate variability,
muscle sympathetic nerve activity
INTRODUCTION
Primary Sjogren syndrome (pSS) is a chronic systemic
autoimmune disease which primarily affects the exocrine
glands, most commonly the salivary and lacrimal glands, leading
to xerostomia and xerophthalmia (Fox, 2005). Its prevalence is
estimated to be about 7 per 100,000 person-years (Qin et al.,
2015). It is characterized by a high female-to-male ratio of 9:1 and
the mean age of onset is around the 4th to 5th decade of life (Qin
et al., 2015). At least a third of patients develop extraglandular
manifestations (Vitali et al., 2002). These may involve the skin
(Ramos-Casals et al., 2004), vessels (Scofield, 2011), joints (Pease
et al., 1993), and muscles (Lindvall et al., 2002). Among the
visceral organs affected are the lungs (Quismorio, 1996), heart
(Gyongyosi et al., 1996), kidneys (Gamron et al., 2000), and the
gastrointestinal tract (Ebert, 2012).
The pathogenesis of pSS involves an abnormal immunological
response to an inflammatory insult in predisposed individuals
which ultimately results in a perpetuated inflammatory response
(Fox, 2005). However, an analysis on sialadenitis progression in
patients with pSS showed no correlation between the degree of
salivary gland destruction and salivary secretions (Jonsson et al.,
1993). Thus, it seems that the severity of clinical manifestation
does not correspond to the degree of organ inflammation, and
therefore symptoms might not be completely attributed to the
inflammatory process alone (Humphreys-Beher et al., 1999).
With exocrine glandular dysfunction being the hallmark of the
disease and as its function is highly regulated by the autonomic
nervous system (ANS) (Proctor and Carpenter, 2007), several
studies aimed to evaluate neural autonomic involvement in the
disease process. Moreover, a range of autonomic symptoms have
been described in pSS patients such as orthostatic hypotension,
urinary retention, and gastroparesis (Mandl et al., 2008; Newton
et al., 2012; Goodman et al., 2017).
Several studies have performed objective autonomic function
assessment in patients with pSS, however, evidence remain
inconclusive. While some investigation, via cardiovascular
autonomic reflex testing, inferred alterations in both
parasympathetic and sympathetic function others observed
parasympathetic dysfunction only or no alteration at all
(Andonopoulos et al., 1998; Barendregt et al., 1999; Mandl
et al., 2001, 2007; Niemela et al., 2003; Kovacs et al., 2004).
Furthermore, conflicting data have also been produced by studies
using spectral analysis of heart rate (HR) variability, a sensitive
non-invasive method to detect early and subtle abnormalities
in cardiovascular autonomic function (Niemela et al., 2000;
Tumiati et al., 2000; Barendregt et al., 2002; Cai et al., 2008;
Ng et al., 2012; Koh et al., 2017). Finally, no data are available
on the baroreceptor control in these patients. As a reminder,
baroreflex sensitivity (BRS) can be used to evaluate autonomic
dysfunction by assessing the efficiency of the baroreflex response
to variations of arterial pressure (AP). The characterization of
baroreflex function is usually carried out via the evaluation of
cardiac baroreflex (cBR) (Smyth et al., 1969; Pickering et al.,
1972) and sympathetic baroreflex (sBR) (Sundlof and Wallin,
1978; Kienbaum et al., 2001) through the estimation of BRS
as the variation of the target variable in correspondence to a
unit change of AP. Consequently, cBR sensitivity (cBRS) is
calculated as the variation of heart period (HP) in response
to modification of systolic AP (SAP) (Smyth et al., 1969;
Pickering et al., 1972). sBR sensitivity (sBRS) is evaluated by
measuring the variation in probability of occurrence of the
muscle sympathetic nerve activity (MSNA) burst per unit change
of diastolic AP (DAP).
Presently, in patients with pSS there is no data on the
functional status of the sympathetic outflow activity to the
vessels, as assessed by microneurography. This technique allows
to directly measure the MSNA, reflecting neural vasoconstriction
activity to intramuscular vessels. We reasoned that given the
possible subclinical vasculitis which has been hypothesized to
be present in these patients (Scofield, 2011), MSNA assessment
would be particularly suitable to add valuable information about
the pathophysiological mechanisms occurring in pSS.
The aim of the current study was therefore to investigate the
characteristics of the BRS, the cardiovascular autonomic profile,
and the sympathetic vasomotor function in patients affected by
pSS compared to healthy controls. The relationship between the
autonomic profile, sympathetic vasomotor function, and clinical
feature in pSS patients was also explored.
MATERIALS AND METHODS
Study Population
Nineteen patients with pSS (18 females and 1 male) and 17
age- and gender-matched healthy controls (15 females and 2
males) were enrolled in the study which was performed at the
Humanitas Clinical and Research Center, Rozzano, Italy. The
pSS patients were referred from the immunological outpatient
clinic of the Humanitas Clinical and Research Center and the
Rheumatology outpatient clinic of L. Sacco Hospital, Milan, Italy.
The patients were previously diagnosed with pSS according to the
revised American European Consensus Group (AECG) criteria
(Vitali et al., 2002).
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At enrollment, the participants underwent a comprehensive
medical history assessment and physical exam and got acquainted
with the clinical laboratory environment to ensure maximal
reproducibility of the results.
Exclusion criteria were applied to both groups as follows:
current human immunodeficiency virus (HIV) and/or hepatitis
C virus (HCV) infection; previous history of cancer or any
lymphoproliferative disease; active pregnancy; substance/alcohol
abuse; presence of comorbidities such as diabetes mellitus,
Parkinson’s disease, chronic kidney disease (stages 4 or 5), other
known systemic autoimmune diseases, sarcoidosis, amyloidosis,
IgG4 disease, ischemic and/or valve heart disease, heart failure,
atrial fibrillation, hypertension, the presence of a pacemaker, and
a previously diagnosed primary dysautonomia.
Following a detailed explanation of the aims and procedures
involved in the study, all study participants provided a signed
informed consent. Because of fear of the microneurography
procedure, seven patients and seven controls selectively did
not give consent to undergo the MSNA recording procedure,
but agreed to undergo the remaining variables recording. The
protocol adhered to the principles of the Helsinki declaration and
was approved by the Humanitas Clinical and Research Center
ethics committee (authorization no. 1395).
Recorded Variables and Experimental
Protocol
The experimental procedures were performed on all participants
during the morning hours (8.30 a.m.–12 p.m.) in a quiet and dim
lighted room, with comfortable temperature. The subjects were
instructed to avoid intense physical activity in the 24 h preceding
the study and to consume a light breakfast and avoid caffeine,
smoking, and alcohol on the day of the investigation. pSS patients
were instructed to suspend the use of pilocarpine 3 days prior to
the study and none of the participants were on other medications
that may affect the ANS function.
For each subject, an electrocardiogram (ECG), non-invasive
AP (Nexfin monitor, BMEYE B.V., Amsterdam, Netherlands),
and respiratory movements by a thoracic belt positioned at mid-
chest level (Respibelt, Francesco Marazza) were continuously
recorded for a period of 15 min while supine.
To allow for cross calibration of the non-invasive beat-to-beat
blood pressure (BP) signal, BP was measured every 3 min by an
automated device (Phillips Comfort Care Adult, cuff size 27.0–
35.0 cm, United States).
A direct recording of the MSNA by microneurographic
technique was performed on 12 pSS patients and 9 controls, both
in the supine position and during head up tilt, a stimulus which
enhances the overall cardiovascular sympathetic activity (Furlan
et al., 2000). MSNA was recorded from the peroneal nerve of the
left leg (Tank et al., 2003; Diedrich et al., 2009). Briefly, multiunit
recordings of postganglionic sympathetic discharge activity were
obtained by a tungsten electrode inserted through unanesthetized
skin into a left peroneal nerve fascicle, posterior to the fibular
head. A reference electrode was inserted subcutaneously, close by
the recording needle. Adjustments in the electrode’s position were
performed until the characteristic signal of sympathetic origin
was detected (Wallin and Fagius, 1988). The raw neural signal was
amplified (1000-fold), band-pass filtered (bandwidth between
700 and 2000 Hz), and rectified and integrated (time constant
of 0.1 s) by a nerve traffic analyzer (model 662C-3; University of
Iowa Bioengineering Department, Iowa City, IA, United States).
Following instrumentation and a preliminary 5-min
adjustment period, supine data acquisition was initiated.
Recordings were continued while the subject underwent a
progressive head up tilt challenge (15◦ increments, up to 75◦
head-up elevation), each level maintained for 3 min. This was
followed by a 5-min recovery period.
The Valsalva maneuver and the sinus arrhythmia (SA) test
were also performed during the 15-min supine recording.
Valsalva ratio, a global index of baroreflex mediated control of
HR and SA ratios, an index of efferent parasympathetic cardiac
modulation, were computed dividing the highest HR value by the
lowest HR value recorded during each of those tests. Details of
the procedure are described elsewhere (Hilz and Dutsch, 2005).
Extraction of the Beat-to-Beat Variability
Series
Electrocardiogram, continuous AP, respiratory activity, and
MSNA were digitized at 400 Hz/channel (ADInstruments,
Powerlab, PL3516/P, Oxford, United Kingdom). The signals were
stored on a personal computer hard disk for offline analysis.
The R-wave peaks were detected using the traditional first-
derivative thresholding method. The temporal distance between
two consecutive identified R-wave peaks was taken as the HP
approximated as RR interval. The maximum value of AP inside
the ith RR interval was defined as the ith SAP value, while
the minimum value before the ith SAP value was taken as the
ith DAP. The identified R-wave peaks and the positions of the
corresponding SAP and DAP values were then manually checked
to avoid erroneous detections or missed beats.
Muscle sympathetic nerve activity bursts were automatically
detected from the integrated MSNA, using an adaptive
thresholding method to account for baseline wandering
(Diedrich et al., 2009). Bursts were searched for in a temporal
window ranging from 0.9 to 1.7 s after each R-wave peak, based
on the known sBR latency, i.e., the conduction time from the
aortic and carotid baroreceptors to the peroneal nerve, which
correspond to approximately 1.3 s (Wallin et al., 1994; Hamner
and Taylor, 2001; Diedrich et al., 2009).
This application was made possible by the exploitation of the
calibrated MSNA series (cMSNA) detailed in a study by Marchi
et al. (2016a) expressing the MSNA variability in bursts/s. Briefly,
the cMSNA signal was obtained from the integrated MSNA signal
by counting the number of MSNA bursts inside a moving time
window of 5 s. The resulting step-wise count MSNA signal was
then low-pass filtered with a finite impulse response filter with
a cutoff frequency of 0.5 Hz, in order to retain exclusively the
frequency range of cardiovascular variability. Finally, the low-
pass count MSNA signal was down-sampled in correspondence
with the first R-wave peak delimiting each ith RR interval. The
resulting time series was expressed in burst/s by dividing the
count cMSNA values by the length of the time window. As
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a result, the beat-to-beat variability of cMSNA = {cMSNA(i),
i = 1,. . . , N} was synchronous with the beat-to-beat variability
series of HR, SAP, and DAP.
Variability Power Spectral Analysis
Analysis was performed in the supine position and during
head up tilt test. The time series length was fixed at 300
consecutive beats in both conditions. The stationarity of the
selected sequence was tested over the original series after linear
detrending (Magagnin et al., 2011). If the test for the steadiness of
mean and variance was not fulfilled, a new selection was carried
out until the prerequisites for restricted weak stationarity were
obtained (Magagnin et al., 2011). Test for the stationarity of the
mean was carried out even after linear detrending.
Power spectral analysis was performed over RR, SAP, and
respiratory series (Pagani et al., 1986; Task Force of the European
Society of Cardiology and the North American Society of Pacing
and Electrophysiology, 1996). The Levinson–Durbin recursion
was used to assess the autoregressive model coefficients and the
variance of the white noise. The number of coefficients was
automatically chosen, based on the Akaike’s figure of merit,
ranging between 8 and 14.
From RR and SAP series we derived the markers of autonomic
control. The high frequency (HFRR) component (0.15–0.4 Hz)
is taken as an index of the vagal efferent modulation directed
to the sinoatrial node and the low frequency (LFRR) component
(0.04–0.15 Hz), which when expressed in normalized units (nu),
is thought to primarily reflect the sympathetic modulation of
the sinoatrial node activity and of its changes (Furlan et al.,
2000), although its functional meaning is still debated (Pomeranz
et al., 1985; Parati et al., 1995). The LFRR/HFRR ratio, a
dimensionless index, assesses the sympatho–vagal relationship
modulating the cardiac sinoatrial node (Pagani et al., 1986;
Furlan et al., 2000), although, recently, a review questioned its
interpretation and use, particularly in psychological research
(Heathers and Goodwin, 2017). The LF component of SAP
variability, indicated as LFSAP, is considered an indirect marker
of the sympathetic vasomotor control (Furlan et al., 2000; Barbic
et al., 2007). Finally, the sympathetic drive directed to the vessels
was evaluated directly through the burst rate of the integrated
MSNA, expressed as bursts/min.
Cardiac and Sympathetic Baroreflex
Estimation
A spectral approach applied to RR and SAP variability was
used to assess cBRS computed as the squared root of the ratio
between LFRR and LFSAP, termed as αLFcBRS, and expressed
in ms mmHg−1 (Pagani et al., 1988; Barbic et al., 2007;
Porta et al., 2013).
Additionally, another approach used for cBRS estimation was
based on the cBR sequence method (Bertinieri et al., 1985) as
implemented by Porta et al. (2000) and is indicated as SEQcBRS
hereafter. Briefly, the methodology is based on the analysis of
sequences of simultaneous increases (positive +/+ sequences)
or decreases (negative −/− sequences) of RR and SAP values.
The sequences in both time series were chosen with a length
equal to four consecutive values and the time lag between SAP
and RR (τRR−SAP) was 0 beats to take into account the fast
vagal arm of the baroreflex (Porta et al., 2013). A spontaneous
cBR sequence was selected only if the following prerequisites
were satisfied (Laude et al., 2004): (1) the absolute value of the
total RR variation was >5 ms; (2) the absolute value of the
total SAP variation was >1 mmHg; (3) the linear correlation
coefficient computed over a given cBR sequence, rRR−SAP, was
>0.85. The percentage of sequences that satisfied the selection
prerequisites with respect to all sequences was calculated and
indicated as SEQ%cBR. Over each sequence the slope of the linear
regression in the plane [SAP(i), RR(i+ τRR−SAP)] was calculated.
The obtained regression slope values were subsequently averaged
over all baroreflex sequences and the resulting value was taken
as an estimate of SEQcBRS, expressed in ms mmHg−1. While
SEQcBRS is taken as a measure of the effectiveness of the cBR,
SEQ%cBR is taken as a measure of the degree of involvement of
cBR (Marchi et al., 2016b).
Regarding sBR, in agreement with the spectral approach
proposed by Pagani et al. (1986), sBRS was estimated using LFsBRS
which was calculated as the squared root of the ratio between
LFcMSNA and LFDAP and expressed in burst s−1 mmHg−1.
Additionally, SEQsBRS was estimated over the cMSNA and
DAP beat-to-beat variability series, with an approach similar to
SEQcBRS. Specifically, sBR sequences were defined with length
equal to four consecutive beats and the lag between the paired
MSNA burst rate and DAP values expressed in beats, termed as
τMSNA−DAP, was set to 1 to account for the sBR latency. The
sequences were then selected to have opposite sign variations
over the two series, i.e., the simultaneous increase of cMSNA
and decrease of DAP values (±sequences) or vice versa (−/+
sequences). The prerequisites necessary for the selection of a
sequence were: (1) the absolute value of cMSNA change >0; (2)
the absolute value of the total DAP variation was >1 mmHg; (3)
the absolute value of the linear correlation coefficient computed
in the [DAP(i), cMSNA(i + τMSNA−DAP)] plane over a given
sBR sequence, rcMSNA−DAP was >0.85 (Marchi et al., 2016b).
The slope of the regression line of each selected cMSNA−DAP
sequence was calculated and subsequently the average of all
slopes (defined as SEQsBRS) was taken as an estimate of sBRS
and expressed in bursts s−1 mmHg−1. The percentage of sBR
sequences with respect to all sequences was computed as well
and indicated as SEQ%sBR. Both indexes were considered with
analogous physiological meaning to the corresponding cBR ones
but with relevance to the sBR arm.
Symptoms and Diseases Activity
Assessment
The assessment of the intensity of clinical symptoms was
obtained by the following questionnaires, filled out by all subjects:
- The EULAR Sjogren’s syndrome patient reported index
(ESSPRI) was used for assessing the overall burden of
disease associated symptoms. Specifically, about levels of
fatigue, overall pain, and sicca symptoms (numerical scale
0–10, with 0 being the absence of symptom and 10 the
greatest symptom intensity) (Seror et al., 2011).
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- The Composite Autonomic Symptom Scale (COMPASS 31)
was used to quantify the following autonomic symptoms:
orthostatic intolerance and vasomotor, secretomotor,
gastrointestinal, and urinary and pupillomotor dysfunction
symptoms (31 items; score range 0–100, with 0 being
the absence of symptom and 100 the greatest symptom
intensity) (Sletten et al., 2012).
Objective markers of disease’s secretory impairment were
assessed only in pSS patients. Salivary gland function was
evaluated by a non-stimulated total salivary flow scialometry test
(positive if ≤1.5 ml/15 min) (Vitali et al., 2002). Signs of ocular
involvement were assessed by the Schirmer test I (positive if
≤5 mm/5 min) and serum was analyzed for the presence of ANA,
RF, anti-SSA, and anti-SSB autoantibodies.
Statistical Analysis
For sample size calculation we focused on the LF/HF ratio
because it was the only variable of interest available in literature.
Sample size calculation was based on the results from Tumiati
et al. (2000) concerning HR variability analysis in patients with
pSS compared with healthy controls. We computed the LF/HF
FIGURE 1 | Correlation between the ESSPRI dryness score and the total
COMPASS 31 score (top graph). Please notice that the higher the dryness
score the greater the autonomic symptoms score (r = 0.6359, p = 0.0036). In
addition, there was an inverse correlation between the dryness score and the
amount of salivary flow (bottom graph, r = –0.6577, p = 0.0061).
ratio difference between Sjogren patients and controls at rest
reported in figure 2 of the above mentioned paper. Based on a
power of 0.8 and a significance level of 0.01 because of potential
multiple comparisons, we estimated the necessary sample size for
our current study to be 11 patients per group. In spite of this
number, we recruited additional patients and controls (i.e., 17
and 19, respectively) to account for potential drop out or for non-
optimal signal to noise ratio in the case of microneurography.
The normality of the data was established by Kolmogorov–
Smirnov test. An unpaired t-student test was used to assess for
differences in mean values between patients and controls.
The Spearman rank correlation test was used for associations
between subjective symptoms, objective markers of disease
activity, and objective autonomic function assessment.
Continuous variables are expressed as mean ± standard
error (SEM). Significance level was set at 5%. GraphPad PrismTM
was used for statistical analysis.
RESULTS
The demographic, hemodynamic, respiratory, and immunologic
characteristics of the pSS patient and control groups are displayed
in Table 1. Due to excessive atrial and ventricular premature
beat activity in the recorded variables, spectral analysis was not
performed on two patients and one control. Thus, final data
analysis was performed on 17 pSS (16 females and 1 male, BMI
20.2 ± 2.8) and 16 age-matched healthy controls (14 females
and 2 males, BMI 21.3 ± 2.1). From this final study population,
because of the absence of written consent and presence of sub-
optimal signal/noise ratio, a MSNA signal adequate for automatic
analysis was obtained for seven pSS patients and seven controls.
Abnormal scialometry (<1.5 ml/15 min) and Schirmer tests
(< 5 mm/5 min) were found in pSS patients and salivary flow
rate was negatively associated with ESSPRI dryness (p = 0.0014).
Disease Activity Indices and Autonomic
Profile
Assessment of autonomic symptom presence and burden of
disease activity showed, as expected, a significantly greater mean
score in pSS group compared to the control group in the total
ESSPRI (18.0 ± 5.2 vs. 5.3 ± 1.7; p < 0.0001), fatigue (6.6 ± 2.2
vs. 3.2± 0.8; p = 0.0051), pain (5.1± 2.7 vs. 1.8± 1.1; p = 0.0057),
and dryness (6.4± 2.3 vs. 0.3± 0.5; p< 0.0001) ESSPRI domains.
With regards to the COMPASS31, a significantly higher
mean score was obtained for the pSS group in the total score
(27.0 ± 10.9 vs. 9.0 ± 5.7; p < 0.0001), secretomotor (3.2 ± 1.5
vs. 0.0 ± 0.0; p < 0.0001), and pupillomotor impairment scores
(7.9 ± 2.9 vs. 2.4 ± 2.9; p = 0.0003). No significant differences
were found in the domains of orthostatic intolerance (3.4 ± 2.5
vs. 0.9 ± 1.3; p = 0.058); vasomotor (2.0 ± 2.9 vs. 0.0 ± 0.0,
p = 0.059); gastrointestinal (8.3 ± 3.9 vs. 5.0 ± 3.3; p = 0.236);
and bladder function (2.2 ± 2.7 vs. 0.7 ± 0.9; p = 0.353)
between the two groups.
Figure 1, upper panel, shows the correlation between the
ESSPRI dryness score and the total COMPASS 31 score. Please
notice that the higher the dryness score the greater the autonomic
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FIGURE 2 | Recorded variables in a representative Sjogren patient and in a control subject while recumbent. Notice the greater burst activity characterizing the
patient’s MSNA compared to the control.
symptoms score (r = 0.6359, 95% CI 0.2088–0.8593, p = 0.0036).
In addition, there was a linear, inverse, relationship between
the dryness score and the amount of salivary flow (lower panel,
r =−0.6577, 95% CI−0.8847 to−0.1784, p = 0.0061).
Baroreflex Sensitivity
Table 2 displays the results both for the cardiac and the
sympathetic arms of the BRS at rest. Regarding the cardiac arm,
SEQcBRS was significantly lower in pSS patients than in controls
whereas the αLFcBRS index was only slightly smaller. αLFcBRS
was significantly decreased (Table 3) during the tilt maneuver
with respect to the resting state in both populations (p = 0.009
in pSS patients and p = 0.030 in healthy controls), as expected
(Furlan et al., 2000).
SEQsBR and αLFsBRS were similar between the two groups at
rest and during tilt (Table 2). In addition, no significant variations
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TABLE 1 | Characteristics of the study population.
Characteristics Patients (n = 17) Controls (n = 16)
Age (years) 57.2 ± 13.7 51.0 ± 13.9
BMI (kg/cm2) 20.2 ± 2.8 21.3 ± 2.1
HR (beats/min) 66.4 ± 3.4 66.3 ± 2.3
SAP (mmHg) 125.3 ± 5.9 116.8 ± 3.6
Resp (cycles/min) 18.7 ± 1.7 16.1 ± 1.0
ANA seropositives n, (%) 15, (88) NA
RF seropositives n, (%) 6, (35) NA
Anti-SSA abs seropositives n, (%) 12, (70) NA
Anti-SSB abs seropositives n, (%) 6, (35) NA
Positive scialometry test n, (%) 11, (65) NA
Positive Schirmer’s test n, (%) 15, (88) NA
BMI, body mass index; HR, heart rate; SAP, systolic arterial pressure;
Resp, respiratory activity; ANA, antinuclear antibodies; RF, rheumatoid
factor autoantibodies; SSA, Sjogren syndrome-related antigen A; SSB,
Sjogren syndrome-related antigen B; NA, not applicable. Data are expressed
as mean ± SEM.
TABLE 2 | Cardiac and sympathetic baroreflex sensitivity (BRS) evaluation by
sequence and spectral methods during supine rest.
Patients Controls
SEQcBRS (ms mmHg−1) 5.58 ± 0.61§ 9.51 ± 0.50
αLFcBRS (ms mmHg−1) 15.9 ± 4.6 18.1 ± 3.2
SEQsBRS (bursts s−1 mmHg−1) −0.11 ± 0.03 −0.10 ± 0.03
αLFsBRS (bursts s−1 mmHg−1) 6.21 ± 1.62 5.03 ± 5.98
SEQcBRS indicates cardiac baroreflex sensitivity calculated over the SAP-RR
spontaneous sequences of cBR origin, by the sequence method, i.e., SAP changes
with same sign of RR variations; αLFcBRS, spectral index of cBR sensitivity,
computed as the square root of the ratio between LFRR and LFSAP; SEQsBRS,
sympathetic baroreflex sensitivity calculated over the DAP-MSNA sequences of
sBR origin, by the sequence method, i.e., DAP changes with opposite sign of the
MSNA burst rate variations; αLFsBRS, spectral index of sBR sensitivity, computed
as the square root of the ratio between LFMSNA and LFDAP. Results are expressed
as mean ± SEM. § p < 0.005 patients vs. controls.
TABLE 3 | Cardiac and sympathetic baroreflex sensitivity (BRS) evaluation by
sequence and spectral methods during 75◦ head-up tilt.
Patients Controls
SEQcBRS (ms mmHg−1) 6.23 ± 1.66 6.77 ± 1.40
αLFcBRS (ms mmHg−1) 6.54 ± 1.83 7.65 ± 1.51
SEQsBRS (bursts s−1 mmHg−1) −0.11 ± 0.01 −0.10 ± 0.03
αLFsBRS (bursts s−1 mmHg−1) 9.43 ± 2.35 9.49 ± 3.24
Remaining abbreviations as in Table 2. Results are expressed as mean ± SEM.
were observed in both indices during tilt in either pSS patients
and healthy controls (Table 3).
Cardiovascular Autonomic Assessment
As to the cardiovascular reflex tests performed in the supine
position, no significant differences were seen between the pSS
group and control group in mean Valsalva ratio values (1.43± 0.1
vs. 1.64 ± 0.09; p = 0.09) and mean SA ratio (1.20 ± 0.03 vs.
1.24± 0.04; p = 0.49).
Figure 2 shows representative examples of the variables that
were recorded while supine in a patient with pSS and in a healthy
control. Notice that MSNA burst rate was greater in the pSS
patient than in the control subject at rest whereas BP and HR were
similar in both individuals.
Tables 4, 5 summarize the mean spectral indices and MSNA
burst activity of sympathetic vasomotor control in the pSS and
control group, both in the supine position and in response to tilt.
In the supine position, the pSS group had significantly lower
LFRR (nu) and higher HFRR (nu) values compared to the control
group. The LF/HF ratio was significantly lower in the patient
group. Figure 3 depicts the differences in the values of the spectral
index of cardiac vagal modulation HFRR in nu and of arterial BRS
SEQcBRS, as observed in Sjogren patients and controls, both at
rest and during the tilt maneuver. At rest HFRR in nu was greater
in patients than in controls. This was associated with lower
arterial BRS. During tilt, SEQcBRS decreased in both patients and
controls, but still HFRR was higher in patients.
No significant differences were observed between the groups
in LFSAP, and in αLF, an index of arterial baroreflex function.
In contrast, neural post-ganglionic sympathetic discharge activity
(MSNA) was significantly greater in pSS patients compared to
controls (Figure 2).
In response to the head up tilt challenge patients and
controls had similar HR (85.8 ± 5.4 and 83.2 ± 3.4 beats/min,
respectively), SAP (126.5 ± 6.5 and 119.1 ± 1 mmHg,
respectively), and respiratory rate (16.1 ± 1.0 and
TABLE 4 | Indices of autonomic function and MSNA in pSS patients and healthy
controls during the supine position.
Supine
Patients Controls
VM ratio 1.43 ± 0.09 1.64 ± 0.09
SA ratio 1.20 ± 0.03 1.24 ± 0.04
R–R interval (ms) 951.1 ± 41.1 907.5 ± 26.9
σ2RR (ms
2) 1725 ± 537 1356 ± 285.4
HFRR (ms2) 593.9 ± 283 237.9 ± 61.7
HFRR (nu) 54.6 ± 5.7∗ 32.8 ± 3.2
LFRR (ms2) 338.4 ± 109 460.8 ± 110
LFRR (nu) 43.2 ± 5.5∗ 63.2 ± 3.6
LF/HF 1.87 ± 0.98∗ 2.48 ± 0.42
SAP (mmHg) 121.6 ± 5.9 114.2 ± 2.9
σ2SAP (mmHg
2) 20.7 ± 4.1 14.4 ± 4.7
LFSAP (mmHg2) 1.83 ± 0.52 1.80 ± 0.41
MSNA (bursts/min) 30.57 ± 2.75∗ 20.71 ± 3.29
MSNA (bursts/100 beats) 49.08 ± 2.68∗ 29.55 ± 2.81
VM ratio indicates the ratio between the highest and the lowest heart rate values
during the Valsalva maneuver; SA ratio, sinus arrhythmia ratio between the highest
and the lowest heart rate values during a 2-min long controlled respiration at 6
breaths per minute; σ 2RR, variance of R–R interval; HF, high frequency component;
LF, low frequency component; LF/HF, ratio between the low frequency and the high
frequency components of RR variability; nu, normalized units; SAP, systolic arterial
pressure; σ2SAP, variance of systolic arterial pressure; MSNA, muscle sympathetic
nerve activity. Data are expressed as mean ± SEM. ∗p < 0.05 patients vs. controls
(Kolmogorov–Smirnov test).
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TABLE 5 | Indices of autonomic function and MSNA in pSS patients and healthy
controls during 75◦ head-up tilt.
75◦ head-up tilt
Patients Controls
R–R interval (ms) 743.1 ± 46.0 727.3 ± 23.8
σ2RR (ms
2) 880.2 ± 203.5 1115.0 ± 212.6
HFRR (ms2) 70.7 ± 18.4 60.0 ± 17.1
HFRR (nu) 33.2 ± 6.8∗ 11.1 ± 1.6
LFRR (ms2) 403.3 ± 113.2 550.8 ± 146.9
LFRR (nu) 56.5 ± 8.8 79.8 ± 4.2
LF/HF 5.48 ± 1.70∗ 10.38 ± 1.82
SAP (mmHg) 117.6 ± 5.43 119.3 ± 3.24
σ2SAP (mmHg
2) 27.67 ± 7.1 15.39 ± 1.4
LFSAP (mmHg2) 10.54 ± 2.97 7.10 ± 1.38
MSNA (bursts/min) 51.14 ± 3.81§ 32.14 ± 3.32
MSNA (bursts/100 beats) 60.33 ± 3.02∗ 38.47 ± 2.31
Abbreviations as in Table 4. Data are expressed as mean ± SEM. ∗p < 0.05
patients vs. controls (Kolmogorov–Smirnov test). § p < 0.005 patients vs. controls
(Kolmogorov–Smirnov test).
18.6 ± 1.6 breaths/min, respectively). MSNA burst rate was
greater in patients (Table 3). The two groups were characterized
by a similar increase in mean LF/HF ratio and LFSAP values
whereas the increase of MSNA was greater in patients compared
to controls (Figure 4).
Post hoc power calculations yielded a statistical power of 56%
with an effect size of 0.87 (medium to large effect, considering
the suggestions from Quintana, 2017). This was calculated on
the variable LF/HF, after a multiple comparison correction of the
significance level.
DISCUSSION
The results of the present study indicate that pSS patients suffer
more from global symptom burden and autonomic dysfunction
symptoms compared to healthy controls, in agreement with a
previous study (Newton et al., 2012). In particular, they scored
markedly higher in the secretomotor and pupillomotor domains,
a finding which is not surprising since sicca symptoms are
considered hallmarks of the disease. Furthermore, in pSS patients
secretomotor dysfunction was strongly associated with decreased
measured salivary production.
It has to be pointed out that spectral analysis of RR variability
revealed subtle abnormalities in the cardiac autonomic control
that would have remained hidden when considering the simple
hemodynamic profile of the two groups in the supine position.
Indeed, while HR, SAP, and respiratory rate mean values were
FIGURE 3 | Box plots showing the differences in the values of the spectral index of cardiac parasympathetic modulation HFRR in nu and of arterial baroreflex
sensitivity SEQcBRS, as observed in Sjogren patients and controls both at rest and during the tilt maneuver. Notice that at rest HFRR was greater in patients
suggesting a prevailing cardiac vagal modulation compared with controls. This was associated with a lower arterial baroreflex control of HR, a finding which points to
the independence of the cardiac vagal modulation from arterial baroreceptor modulation in Sjogren patients at rest. During tilt, SEQcBRS decreased in both patients
and controls but still HFRR was higher in patients than in healthy controls further highlighting its independence from baroreceptor modulation. HFRR indicates the high
frequency oscillatory component of RR interval variability; SEQcBRS is the index of arterial baroreflex sensitivity obtained by the spontaneous sequences method.
∗p < 0.05.
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FIGURE 4 | Changes induced by the gravitational stimulus (75◦ head-up tilt)
on the spectral index of cardiac sympatho-vagal balance LF/HF, sympathetic
vasomotor control LFSAP, and on the neural post-ganglionic sympathetic
(MSNA) burst activity in patients (left box plot) and in healthy controls (right
box plot). In response to tilt, patients were characterized by a greater increase
in the sympathetic discharge activity to the vessels compared to controls in
the presence of similar enhancement of the spectral index, LFSAP. This latter
assesses both the sympathetic vasomotor control and the arteries smooth
muscle responsiveness. ∗p = 0.03.
similar in pSS patients and controls, patients were characterized
by markedly higher HFRR (nu), an index of vagal efferent
modulation directed to the sinoatrial node. In addition, the
LF/HF ratio was lower in pSS, reflecting a shift of the sympatho–
vagal instantaneous modulation toward vagal predominance
compared to controls. These findings are in keeping with
previous observations (Tumiati et al., 2000). In addition, such
cardiac parasympathetic prevalence might reflect an autonomic
compensatory mechanism in a setting of a potentially reduced
local exocrine glands cholinergic sensitivity (Imrich et al., 2015),
in turn accounting for the sicca symptoms such as xerostomia
and xerophthalmia.
In response to head up tilt, even though both groups
demonstrated an increase in cardiac sympathetic modulation, an
expected response to orthostatic challenge (Furlan et al., 2000),
the increase in both the LFRR (nu) and LF/HF ratio was milder
in pSS patients, indicating a relative impairment in sympathetic
function or insufficient withdrawal of cardiac vagal modulation,
which is in keeping with previously reported data (Cai et al.,
2008; Ng et al., 2012). Although the functional meaning of the LF
component of RR variability is still controversial (Pomeranz et al.,
1985; Parati et al., 1995) altogether, the changes in HFRR nu and
in the LF/HF ratio suggest that pSS patients were characterized by
predominant cardiovagal modulatory activity at rest and possibly
an attenuated capability to properly decrease their cardiac vagal
modulation in response to the orthostatic stimulus, compared to
healthy controls.
In the current investigation arterial baroreflex sensitivity
was lower in pSS patients than in controls, as assessed in the
time domain by the sequences technique. A similar pattern,
although not statistically significant, was observed when arterial
baroreceptor function was evaluated in the frequency domain
by the αLFcBRS index. The presence of an enhanced cardiac
parasympathetic modulation in a setting of reduced arterial
baroreflex sensitivity as observed in our Sjogren patients is
surprising, since it diverges from most of the physiological
(Furlan et al., 2000; Laude et al., 2004; Marchi et al., 2016b)
and pathophysiological (Pagani et al., 1988; Barbic et al.,
2007) conditions where a decreased baroreceptor sensitivity
was found to be associated with a reduced, rather than
enhanced, cardiac parasympathetic activity. These patterns
may suggest the independence of the cardiac autonomic
profile from arterial baroreceptor activity in Sjogren patients
while supine, highlighting the potential role of a centrally
mediated enhanced cardiac vagal modulation (Figure 3).
During tilt, both SEQcBRS and αLFcBRS index decreased in
patients similarly to healthy controls, thus suggesting a normal
arterial baroreceptor unloading during the gravitational stimulus.
However, still HFRR was greater in patients than in controls
(Figure 3) further highlighting its independence from the
baroreceptor modulation.
Although the presence of both autonomic symptoms and
cardiac sympatho–vagal control disturbances were observed, no
association was found between spectral indices of cardiac neural
control and symptoms, as was also reported by others (Mandl
et al., 2007, 2008).This might be due to differences in the
underlying pathological mechanisms leading to the symptoms
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and objective signs in pSS (Waterman et al., 2000; Dawson et al.,
2006; Mandl et al., 2010).
The pathogenesis responsible for the sicca symptoms in pSS
is still under investigation. Symptoms may result from end organ
damage with decreased responsiveness to autonomic modulatory
activity or from a dysfunction of the ANS itself or from both.
Notably, although autoimmune and inflammatory processes are
involved in the destruction of exocrine glands in pSS, there seems
to be no association between the degree of damage and glands
functional status (Imrich et al., 2015). However, there is some
evidence pointing to a cholinergic dysfunction affecting those
glands, which seems to take place independently of the damage
produced by inflammation (Imrich et al., 2015). This is also
supported by the fact that, Pilocarpine, a parasympathomimetic
drug and a mainstay treatment for pSS, improves salivary
secretions (Ramos-Casals et al., 2010). Furthermore, a previous
study suggested that central regulation of cholinergic activity
seemed unaffected in pSS and it was therefore proposed that
cholinergic dysfunction occurs at the peripheral or exocrine gland
level (Imrich et al., 2015). This lends further support, although
indirect, to the role of autonomic abnormalities as possible
etiopathogenetic mechanism in pSS.
In the present study, the fact that pSS patients showed an
overactive cardiac parasympathetic modulation might reflect the
attempt to regulate and overcome a cholinergic dysfunction
possibly originating at the glandular level, in the effort to
maintain some secretory capability. This parasympathetic over-
activity was however reflected by HR variability changes and not
by mean HR modifications, a divergent pattern which can be
observed in other pathophysiological condition such as vasovagal
syncope (Furlan et al., 1998b).
The combined use of power spectral analysis of SAP variability
and the direct post-ganglionic sympathetic neural discharge
recordings enabled the detection of additional alterations in the
vascular autonomic control in pSS. At rest the spectral index
LFSAP, a non-invasive marker of the sympathetic vasomotor
control, was similar in both groups and in keeping with
previous findings (Cai et al., 2008), whereas MSNA burst
rate was greater in pSS. The discrepancy in the MSNA
activity compared to LFSAP at rest is unusual in a setting of
normal sympathetic baroreceptor modulatory activity. Indeed,
conditions leading to an increase of the MSNA, such as
the presence of an hyper adrenergic state like that observed
in POTS (Furlan et al., 1998a) or in response to up-
right position in healthy individuals (Furlan et al., 2000),
were found to be paraleled by similar changes of LFSAP
(Furlan et al., 2000).
Despite the limited number of patients in the current study,
taken together these findings indicate that in the supine position
pSS patients exhibit discordant cardiac and vascular sympathetic
control characterized by predominant vagal cardiac modulation
and greater sympathetic nerve activity targeting the vessels.
There might be several possible explanations accounting for
this possible discrepancy. It could potentially be the result of
a peripheral compensatory response in the attempt to balance
the excessive parasympathetic cardiac activity. Alternatively,
the sympathetic post-ganglionic discharge activity could have
been enhanced in response to peripheral vascular damage due
to subclinical vasculitis. This might reduce the capability of
the arterial smooth muscle of adequately contracting under
the sympathetic firing, similarly to what was observed in
the healthy subjects of the current study. Notably, it has
been shown that peripheral and visceral vasculitis in pSS
patients were strongly associated with the presence of anti-
SSA/-SSB autoantibodies (Scofield, 2011), a finding that was
as high as 80% in our pSS population. The observation of
a mismatch between an enhanced MSNA and a concomitant
“normal” LFSAP at rest in pSS compared to controls mimics
what was previously observed after atenolol administration
in healthy subjects (Cogliati et al., 2004) and points to a
possible similar underlying mechanism. This latter may be a
potential mismatch between the neural sympathetic vasomotor
modulation and the target vascular response. In addition,
LFSAP is a comprehensive index of the sympathetic control
of the vessels. It reflects both neural vasomotor control as
well as arterial smooth muscle responsiveness (Furlan et al.,
1990; Diedrich et al., 2003). Conversely, MSNA is a direct
measure of the sympathetic post-ganglionic neural discharge
to the arteries (Delius et al., 1972a,b; Sanders et al., 1988).
Therefore, although MSNA burst rate and LFSAP are both
related to the sympathetic vascular control, they are not
equal, such that to some extent the latter also reflects
the integrity of the target organ, i.e., the vascular smooth
muscle functioning.
The fact that sympathetic baroreceptor modulation of
MSNA was similar in patients and controls in the presence
of greater sympathetic firing must be pointed out. It
suggests the presence of primary central sympathetic over-
activity in our pSS patients, independently of baroreceptor
sympathetic inhibitory modulation which was comparable
to that of healthy controls. Therefore, the existence of
peripheral vascular damage induced by possible chronic
subclinical inflammation, previously described in pSS (Fox,
2005; Scofield, 2011), could potentially cause a blunted
vessel response to sympathetic vasoconstrictor stimuli.
Consequently, in order to produce proper vasoconstriction
and maintain adequate BP values similar to healthy age-
matched individuals, a greater amount of sympathetic
firing might be necessary in pSS patients. The greater
increase of MSNA observed in pSS during tilt compared to
controls, in the presence of similar SAP and LFSAP values
in the two groups, seems to lend further support to the
present hypothesis.
Limitations
The current investigation is a preliminary study with a small
number of participants. This is partially due to the presence in
the protocol of an invasive procedure, i.e., the direct recording
of the neural sympathetic discharge activity. Thus, results and
conclusions should be carefully considered.
In our interpretation of the results, we are proposing
still unconfirmed hypotheses rather than drawing definite
conclusions. Future studies based on larger pSS populations
might help to confirm the present etiopathogenic hypotheses.
Frontiers in Physiology | www.frontiersin.org 10 August 2019 | Volume 10 | Article 1104
fphys-10-01104 August 24, 2019 Time: 16:29 # 11
Brunetta et al. Autonomic Profile in Sjogren Syndrome
Finally, the post hoc power calculations regarding LF/HF ratio
was found to be 56%. One may argue that such a value is low
especially when compared to the original value of the power set
a priori to calculate the sample size of our study based on Tumiati
et al. (2000), namely 0.8. This discrepancy is likely to be related to
a larger variability in our group. It has to be pointed out that a low
statistical power raises the possibility of a type II error, i.e., the
presence of false negative results that, however, should not affect
our interpretation of the findings mainly based on discussing
positive results (i.e., significant differences).
CONCLUSION
The results of the current study revealed the presence of subtle
disturbances in the cardiac autonomic control in pSS patients,
namely a dominant cardiac parasympathetic modulation at rest
with reduced cBR control of HR. Furthermore, direct recording
of the sympathetic post-ganglionic neural discharge to vessels
by microneurography technique detected the presence of a
greater sympathetic nerve activity in patients, both while supine
and in response to gravitational challenge. In a setting of
preserved sympathetic baroreceptor control, we hypothesized
that a primary enhanced sympathetic vasoconstrictor activity
would be required to keep BP values stables, if a possible chronic
subclinical vasculitis were present.
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